Published Date: 26 Apr 2023
In a preclinical study, a novel method of CAR T-cell therapy against small cell lung cancer (SCLC) has shown great promise. Our knowledge of CAR T has been expanded by the findings.
Read Full NewsDrug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.
Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.
1.
Reversing the toxic relationship with high doses of chemotherapy in oncology.
2.
RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung
3.
We Can Advance Our Patients' Healing by One Step With 1,000 Paper Cranes.
4.
Does diabetes impact the prognosis of people with colorectal cancer?
5.
Are patients with advanced cancer receiving treatment aligned with their goals?
1.
Tumor Microenvironment Targeting: Mechanisms, Clinical Implications, and Therapeutic Advances
2.
Clinical Methods in Hematology and Quality Improvement
3.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
4.
Hematologic Toxicity of CDK4/6 Inhibitors in Breast Cancer: Meta-Analysis and Safety Data
5.
Uncovering the Mysteries of the RDW Blood Test
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
5.
Navigating the Complexities of Ph Negative ALL - Part XII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation